Reduced 5-Methylcytosine Level as a Potential Progression Predictor in Patients with T1 or Non-Invasive Urothelial Carcinoma

This study aims to elucidate the level of DNA methylation in urothelial carcinomas (UCs) using 5-methylcytosine (5-MeC) immunohistochemistry (IHC). We examined the relationship among 5-MeC levels, DNA (cytosine-5)-methyltransferase 1 (DNMT1) immunostaining levels, and clinicopathologic features. Tis...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Chi-Jung, Chang, Chao-Hsiang, Chuu, Chih-Pin, Yang, Chi-Rei, Chang, Yi-Huei, Huang, Chi-Ping, Chen, Wen-Chi, Chung, Mu-Chi, Chang, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307268/
https://www.ncbi.nlm.nih.gov/pubmed/25561224
http://dx.doi.org/10.3390/ijms16010677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307268/
https://www.ncbi.nlm.nih.gov/pubmed/25561224
http://dx.doi.org/10.3390/ijms16010677

Ejemplares similares